Rembrandt Dijkerman

Rembrandt Dijkerman possesses a robust background in microbiology and clinical research, beginning with a Master’s degree in Chemistry and Microbiology from Radboud University in 1990. A PhD student at Radboud University Nijmegen from 1992 to 1997, Rembrandt focused on (Hemi)cellulolytic enzymes from anaerobic fungi. Following this, a role as a Clinical Research Associate at IMRO TRAMARKO International BV from 1998 to 2001 was undertaken, followed by a position as a (Senior) Clinical Research Associate at Eli Lilly NL from 2001 to 2005. Rembrandt then advanced to Trial Form Support BV in 2010, holding various managerial roles, including Unit Manager Clinical Operations and Manager Project Delivery, continuing to contribute in a leadership capacity since 2014.